DiscoveryBioMed, Inc. is pleased to announce that Dr. Grace Salzer has joined DBM as a principal scientist. “We continue to find wonderful, young and energetic talent from the University of Alabama at Birmingham, “ explained Dr. Erik Schwiebert, DBM’s CEO and CSO. “Newly minted Ph.D. scientists can work independently and can wear multiple hats, something critical to our scientific teams and programs at DBM. Grace is the latest key hire for us and she will work on the formation of two new scientific units within DBM’s CRO services business.” Grace completed her Ph.D. in 2020 from UAB in work focused on sudden cardiac rhythm arrest and the role of pannexins, extracellular purinergic signaling, and calcium channels and transporters in the heart.
DBM will have more news updates regarding new sectors of its CRO services business in the coming months.